OpenVSafe by OpenVAERS
Search V-safe

94A-13559-67492

5 vaccinations 16 coded responses 44 check-ins 16 free-text entries 3 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
329 / FL
Registered
2021-01-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-14
    Registered in v-safe
  2. 2021-01-14
    Dose 1 — Moderna
  3. 2021-01-14
    Survey response — day 0, dose 1
    MedDRA: Injection site pain — Feeling: Good
    Free text: Minimal injection site soreness such as with influenza vaccine. Not actual pain
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-01-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-21
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-28
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-02-04
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-02-11
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-12
    Dose 2 — Moderna
  11. 2021-02-12
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-02-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  13. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness · None
    Adult check-in
  14. 2021-02-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-02-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site pain — Feeling: Good · Site: Pain
    Free text: Very mild tenderness at injection site. Otherwise not painful
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-02-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-02-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site discomfort, Injection site pain — Feeling: Good · Site: Pain
    Free text: The pain at injection site is minimal. Extremely mild to deep palpation.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-03-05
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-12
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-19
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-26
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-14
    Survey response — 3 months, dose 2
    MedDRA: Pre-existing disease — Feeling: Good
    Free text: Basil Cell Carcinoma
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-08-14
    Survey response — 6 months, dose 2
    MedDRA: Basal cell carcinoma, Bronchitis, Cough, Dyspnoea — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Severe bronchitis with cough and sob. Basil cell carcinoma
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  26. 2021-08-14
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-08-20
  28. 2021-10-24
    Dose 3 — Moderna
  29. 2021-10-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: Vertigo — Feeling: Fair · Site: Pain
    Free text: Vertigo
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Vertigo — Feeling: Fair · Site: Pain
    Free text: Vertigo
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-10-28
    Survey response — days 1–6 daily, dose 3
    MedDRA: Vertigo — Feeling: Fair · Site: Pain
    Free text: Vertigo nocturnal severe
    MedDRA releases: 2024-11 · check-in free text available
  32. 2021-10-29
    Survey response — days 1–6 daily, dose 3
    MedDRA: Vertigo positional — Feeling: Fair
    Free text: Severe vertigo after being supine
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-10-30
    Survey response — days 1–6 daily, dose 3
    MedDRA: Vertigo positional — Feeling: Fair
    Free text: Vertigo from supine to upright persists
    MedDRA releases: 2024-11 · check-in free text available
  34. 2021-10-31
    Survey response — day 7, dose 3
    MedDRA: Vertigo — Feeling: Fair
    Free text: Vertigo persists
    MedDRA releases: 2024-11 · check-in free text available
  35. 2021-11-07
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  36. 2021-11-14
    Survey response — day 21, dose 3
    MedDRA: Vertigo — Feeling: Fair
    Free text: Vertigo which began 36 hours after Moderna booster.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-11-22
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  38. 2021-11-28
    Survey response — day 35, dose 3
    MedDRA: Nystagmus, Vertigo positional — Feeling: Fair
    Free text: I continue to have positional objective vertigo with change from upright to supine or supine to upright. Several brief episodes of vertical nystagmus during the vertigo only as text on phone was rapidly "shuttering " vertically. I'm a physician.
    MedDRA releases: 2024-11 · check-in free text available
  39. 2021-12-05
    Survey response — day 42, dose 3
    MedDRA: Vertigo positional — Feeling: Fair
    Free text: Positional vertigo worse on a few days
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-01-24
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  41. 2022-04-14
    Dose 4 — Moderna
  42. 2022-04-19
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  43. 2022-04-21
    Health check-in — day 7, dose 4
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  44. 2022-04-28
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  45. 2022-05-05
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  46. 2022-05-12
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  47. 2022-05-19
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  48. 2022-05-26
    Health check-in — day 42, dose 4
    Feeling: Fair
    Adult check-in
  49. 2022-07-14
    Survey response — 3 months, dose 4
    MedDRA: COVID-19, Cough, Malaise, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Covid-19 infection with malaise, rhino-rhea, cough and sore throat
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-07-14
    Report sent to call center — 3 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  51. 2022-07-15
  52. 2022-07-15
  53. 2022-07-18
  54. 2022-07-18
  55. 2022-10-13
    Survey response — 6 months, dose 4
    MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Covid 19
    MedDRA releases: 2024-11 · check-in free text available
  56. 2022-10-13
    Report sent to call center — 6 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  57. 2022-10-14
  58. 2022-10-14
  59. 2022-10-14
  60. 2022-10-20
    Call successful
    Does not wish to fill out VAERS report
  61. 2022-10-20
    Call successful
    Does not wish to fill out VAERS report
  62. 2022-10-20
    Call successful
    Does not wish to fill out VAERS report
  63. 2022-11-01
    Dose 5 — Moderna
  64. 2023-05-03
    Health check-in — 6 months, dose 5
    Feeling: Fair
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-14Moderna
22021-02-12Moderna
32021-10-24Moderna No
42022-04-14Moderna No
52022-11-01Moderna No

Call center

3 call center cases

3 successful

See the call center timeline

Free text

Release 2 — day 0, dose 1

2021-01-14

Systemic reaction (other): Minimal injection site soreness such as with influenza vaccine. Not actual pain

Release 4 — days 1–6 daily, dose 2

2021-02-16

Systemic reaction (other): Very mild tenderness at injection site. Otherwise not painful

2021-02-18

Systemic reaction (other): The pain at injection site is minimal. Extremely mild to deep palpation.

Release 8 — 3 months, dose 2

2021-05-14

Symptoms: Basil Cell Carcinoma

Release 9 — 6 months, dose 2

2021-08-14

Symptoms: Severe bronchitis with cough and sob. Basil cell carcinoma

Release 10 — days 1–6 daily, dose 3

2021-10-26

Systemic reaction (other): Vertigo

2021-10-27

Systemic reaction (other): Vertigo

2021-10-28

Systemic reaction (other): Vertigo nocturnal severe

2021-10-29

Systemic reaction (other): Severe vertigo after being supine

2021-10-30

Systemic reaction (other): Vertigo from supine to upright persists

Release 10 — day 7, dose 3

2021-10-31

Systemic reaction (other): Vertigo persists

Release 10 — day 21, dose 3

2021-11-14

Symptoms: Vertigo which began 36 hours after Moderna booster.

Release 10 — day 35, dose 3

2021-11-28

Symptoms: I continue to have positional objective vertigo with change from upright to supine or supine to upright. Several brief episodes of vertical nystagmus during the vertigo only as text on phone was rapidly "shuttering " vertically. I'm a physician.

Release 10 — day 42, dose 3

2021-12-05

Symptoms: Positional vertigo worse on a few days

Release 12 — 3 months, dose 4

2022-07-14

Symptoms: Covid-19 infection with malaise, rhino-rhea, cough and sore throat

Release 12 — 6 months, dose 4

2022-10-13

Symptoms: Covid 19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBasal cell carcinoma ✓ · ✓
SDBronchitis ✓ · ✓
SDCough ✓ · ✓
SDCOVID-19 · · ✓
SDDyspnoea ✓ · ✓
SDMalaise · · ✓
SDNystagmus · · ✓
SDOropharyngeal pain · · ✓
SDPre-existing disease ✓ ✓ ✓
SDRhinorrhoea · · ✓
SDVertigo · · ✓
SDVertigo positional · · ✓
SROInjection site discomfort ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROVertigo · · ✓
SROVertigo positional · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release